Title : Lack of Response to Imatinib in Melanoma Carrying Rare KIT Mutation p.T632I.

Pub. Date : 2019 Jan-Apr

PMID : 31043947






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Lack of Response to Imatinib in Melanoma Carrying Rare KIT Mutation p.T632I. Imatinib Mesylate KIT proto-oncogene, receptor tyrosine kinase Homo sapiens
2 There is a diversity of spectrum of KIT mutations, with some of them rendering tumors responsive to imatinib, while others being imatinib-resistant or not studied yet. Imatinib Mesylate KIT proto-oncogene, receptor tyrosine kinase Homo sapiens
3 There is a diversity of spectrum of KIT mutations, with some of them rendering tumors responsive to imatinib, while others being imatinib-resistant or not studied yet. Imatinib Mesylate KIT proto-oncogene, receptor tyrosine kinase Homo sapiens